The Effect of the Beeswax-containing Barrier on the Prevention of Nipple Crack

Sponsor
Karabuk University (Other)
Overall Status
Completed
CT.gov ID
NCT04259320
Collaborator
Istanbul University-Cerrahpasa (Other), Karabuk Training and Research Hospital (Other)
90
1
3
9.4
9.5

Study Details

Study Description

Brief Summary

In the planned study, it was aimed to evaluate the effectiveness of the beeswax-containing barrier and breast milk used in the first ten days of breastfeeding to prevent the formation of nipple cracks. It's a prospective, randomized study based on 90 primipara lactating women. Participants were assigned randomly 3 groups (beeswax-containing barrier, breast milk, and no treatment-control).

Condition or Disease Intervention/Treatment Phase
  • Device: Beeswax containing barrier
  • Biological: Breast milk
N/A

Detailed Description

Current evidence-based guidelines report that the incidence of nipple cracks ranges between 34-96%. Nipple cracks generally occur in the first week after the birth and may continue in the following periods of breastfeeding. Nipple crack is the second most common reason to stop breastfeeding early, after perceived insufficient milk release. Nipple crack pain in studies has been expressed as extremely painful and terrible. It is known that breast milk, olive oil, quince seed jelly, mint juice, lanolin, jujube fruit lotion, guaiazulen pomade, aloe vera gel, menthol essence, vitamin A-E, curcumin extract, hydrogel dressings are recommended to mothers to prevent nipple cracks during breastfeeding. The prevention of nipple cracks, will successfully allow to continue breastfeeding. In this way, breastfeeding will not be interrupted and the rate of breastfeeding-only feeding will increase in the first 6 months. Using non-pharmacological, effective and therapeutic methods will also have a positive effect to increase the rate of breastfeeding.

Studies in the literature cover the evaluation of the effectiveness of beeswax or beeswax-containing mixtures on wound, burn and crack healing. Due to its natural composition with antioxidant, antimicrobial, and antiulcerative properties, beeswax is thought to be an effective and sufficient material in preventing and healing nipple cracks.

In this study, it is planned to include 90 lactating women (30 women in each group) to meet the parametric test assumptions in the experimental and control groups (beeswax-containing barrier, breast milk, and no treatment-control). Breastfeeding mothers to be included in the experimental and control groups will be randomized.

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized clinical trialRandomized clinical trial
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of the Use of Beeswax-containing Barrier on the Prevention of Nipple Crack in Lactating Primiparous Women Within the First 24 Hours After Giving the Birth: A Randomized Controlled Trial
Actual Study Start Date :
Feb 17, 2020
Actual Primary Completion Date :
Jun 30, 2020
Actual Study Completion Date :
Nov 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Beeswax containing barrier

Beeswax containing barrier will be given to the breastfeeding mother within the first 24 hours. After breastfeeding, it can be placed on the breast after it is expected to dry a little.Outside of breastfeeding and bathing, it will be constantly attached to the breasts.

Device: Beeswax containing barrier
Use beeswax containing barrier on each nipple after each breastfeeding.

Experimental: Breast milk

After breastfeeding, 2-3 drops of breast milk are applied to the nipple and areola. After the milk has dried, the breasts are closed. This application should be done at least 5 times a day.

Biological: Breast milk
Apply breast milk on each nipple and areola after each breastfeeding.

No Intervention: No treatment- control

It is a group that does not use any method to prevent nipple cracks. All follow-ups in the experimental groups are done.

Outcome Measures

Primary Outcome Measures

  1. Nipple crack change [Change from baseline nipple crack at 10 days]

    Use Nipple Crack score 0-3 (Nipple cracks increase as the score increases)

Secondary Outcome Measures

  1. Severity of nipple pain change [Change from baseline severity of nipple pain at 10 days.]

    Use Numeric Rating Scale 0-10 point (The severity of pain increases as the score increases)

Other Outcome Measures

  1. Presence of nipple pain change [Change from baseline presence of nipple pain at 10 days.]

    Questionary (Yes/No)

  2. Maternal satisfaction [Baseline from baseline nipple crack at 10 days]

    Questionary (Use the satisfaction categories-likert)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being over 18 years old;

  • Normal spontaneous delivery.

  • Pregnancy weeks between 37-42.

  • Single birth.

  • Initiated breastfeeding.

  • Having given birth to a healthy, full-term child.

  • Newborn with no oral, palatal or maxillofacial abnormalities.

  • Not taking any medication, considering that drug use may cause nipple problems.

  • Being able to read and write.

  • Volunteering to participate in the study.

  • Not having contraindications for breastfeeding.

Exclusion Criteria:
  • Not approving to participate in the research.

  • Being a multipara.

  • Not breastfeeding within the first 24 hours.

  • Development of any breast problem: Mastitis, engorgement etc.

  • Taking newborn into intensive care.

  • Not sticking to the application.

  • Using another nipple crack preventing method during application.

  • Being allergic to beeswax.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karabuk University Training and Research Hospital Karabük Merkez Turkey 07780

Sponsors and Collaborators

  • Karabuk University
  • Istanbul University-Cerrahpasa
  • Karabuk Training and Research Hospital

Investigators

  • Study Director: Sibel Mutlu, OB/GYN, Karabuk University Research and Training Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Seda Serhatlioglu, Principal Investigator, Karabuk University
ClinicalTrials.gov Identifier:
NCT04259320
Other Study ID Numbers:
  • E-01
First Posted:
Feb 6, 2020
Last Update Posted:
Oct 25, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 25, 2021